Methylation profiling of rectal cancer identifies novel markers of early-stage disease

British Journal of Surgery

Volumn 98, Issue 5, 2011, Pages 724-734

  Leong, K J ^a   Wei, W ^a   Tannahill, L A ^a   Caldwell, G M ^a   Jones, C E ^a   Morton, D G ^a   Matthews, G M ^a   Bach, S P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; DNA METHYLATION; DNA SEQUENCE; EARLY DIAGNOSIS; FEMALE; GENETIC MARKER; GENETICS; HUMAN; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RECTAL NEOPLASMS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 79953678639     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7422     Document Type: Article

References (35)

1. Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, et al., A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg 2009; 96: 280-290.
2. Frangioni JV,. New technologies for human cancer imaging. J Clin Oncol 2008; 26: 4012-4021.
3. Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, et al., The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 2009; 45: 365-373.
4. Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, et al., Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 2010; 28: 3219-3226.
5. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP,. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-196. (Pubitemid 27435555)
6. Kondo Y, Issa JP,. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29-39. (Pubitemid 38221595)
7. de Maat MF, van de Velde CJ, van der Werff MP, Putter H, Umetani N, Klein-Kranenbarg EM, et al., Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol 2008; 26: 2327-2335.
8. Hartmann O, Spyratos F, Harbeck N, Dietrich D, Fassbender A, Schmitt M, et al., DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. Clin Cancer Res 2009; 15: 315-323.
9. Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, et al., Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 2009; 27: 3161-3168.
10. Kapiteijn E, Putter H, van de Velde CJ,. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89: 1142-1149. (Pubitemid 34989221)
11. de Maat MF, van de Velde CJ, Benard A, Putter H, Morreau H, van Krieken JH, et al., Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 2010; 16: 2811-2818.
12. Verma M, Srivastava S,. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol 2002; 3: 755-763. (Pubitemid 35446745)
13. Laird PW,. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003; 3: 253-266. (Pubitemid 37328861)
14. Joensuu EI, Abdel-Rahman WM, Ollikainen M, Ruosaari S, Knuutila S, Peltomaki P,. Epigenetic signatures of familial cancer are characteristic of tumor type and family category. Cancer Res 2008; 68: 4597-4605.
15. Worsham MJ, Chen KM, Meduri V, Nygren AO, Errami A, Schouten JP, et al., Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 668-677. (Pubitemid 43927046)
16. Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, et al., Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS One 2008; 3: e2079.
17. Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R, et al., Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 2009; 101: 124-131.
18. Belshaw NJ, Elliott GO, Foxall RJ, Dainty JR, Pal N, Coupe A, et al., Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer 2008; 99: 136-142. (Pubitemid 351920230)
19. Lee S, Hwang KS, Lee HJ, Kim JS, Kang GH,. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004; 84: 884-893. (Pubitemid 38833248)
20. Kim HC, Roh SA, Ga IH, Kim JS, Yu CS, Kim JC,. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 2005; 20: 1920-1926. (Pubitemid 43961051)
21. Tanaka J, Watanabe T, Kanazawa T, Tada T, Kazama Y, Tanaka T, et al., Left-sided microsatellite unstable colorectal cancers show less frequent methylation of hMLH1 and CpG island methylator phenotype than right-sided ones. J Surg Oncol 2007; 96: 611-618. (Pubitemid 350191487)
22. Sugai T, Habano W, Jiao YF, Tsukahara M, Takeda Y, Otsuka K, et al., Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006; 8: 193-201. (Pubitemid 43811242)
23. Launoy G, Pottier D, Gignoux M,. [Proximal and distal cancers of the colon: 2 epidemiologically different cancers.] Gastroenterol Clin Biol 1989; 13: 255-259. (Pubitemid 19125636)
24. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP,. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96: 8681-8686. (Pubitemid 29354851)
25. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A,. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002; 160: 1823-1830. (Pubitemid 34525661)
26. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, et al., Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417-422. (Pubitemid 38437267)
27. Judson H, Stewart A, Leslie A, Pratt NR, Baty DU, Steele RJ, et al., Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas. J Pathol 2006; 210: 344-350. (Pubitemid 44660513)
28. Cheng YW, Pincas H, Bacolod MD, Schemmann G, Giardina SF, Huang J, et al., CpG island methylator phenotype associates with low-degree chromosomal abnormalities in colorectal cancer. Clin Cancer Res 2008; 14: 6005-6013.
29. Chen SP, Chiu SC, Wu CC, Lin SZ, Kang JC, Chen YL, et al., The association of methylation in the promoter of APC and MGMT and the prognosis of Taiwanese CRC patients. Genet Test Mol Biomarkers 2009; 13: 67-71.
30. Kim YT, Park JY, Jeon YK, Park SJ, Song JY, Kang CH, et al., Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus 2009; 22: 143-150.
31. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, et al., Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008; 68: 8541-8546.
32. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, Murtaugh MA, et al., Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005; 129: 837-845. (Pubitemid 41242676)
33. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al., CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009; 58: 90-96.
34. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41: 178-186.
35. Belshaw NJ, Pal N, Tapp HS, Dainty JR, Lewis MP, Williams MR, et al., Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa. Carcinogenesis 2010; 31: 1158-1163.